Видео ютуба по тегу Ras-Targeted Therapies

The evolving landscape of targeted therapies for RAS-mutated colorectal cancers
The evolving landscape of targeted therapies for RAS-mutated colorectal cancers
Day 2 | K RAS Targeting – The Cusp of a Game Changer Target - Axel Grothey, MD – West Cancer Center
Day 2 | K RAS Targeting – The Cusp of a Game Changer Target - Axel Grothey, MD – West Cancer Center
RAS-Targeted Strategies in Pancreatic Cancer Progress and Future Directions
RAS-Targeted Strategies in Pancreatic Cancer Progress and Future Directions
Expanding KRAS-targeted therapies with RMC compounds and pan-RAS inhibitors
Expanding KRAS-targeted therapies with RMC compounds and pan-RAS inhibitors
Debate: Targeted therapy for RAS/BRAF WT left sided colon cancers - Bevacizumab or EGFR antibodies
Debate: Targeted therapy for RAS/BRAF WT left sided colon cancers - Bevacizumab or EGFR antibodies
Charles Fuchs, MD: RAS Mutations and the Sequence of Therapies
Charles Fuchs, MD: RAS Mutations and the Sequence of Therapies
Developing Therapies for Ras-driven Cancers
Developing Therapies for Ras-driven Cancers
Understanding Targeted Therapies
Understanding Targeted Therapies
Debate: Targeted therapy for RAS/BRAF WT left sided colon cancers - EGFR antibodies are mandatory
Debate: Targeted therapy for RAS/BRAF WT left sided colon cancers - EGFR antibodies are mandatory
TRACO 2019 - K-RAS and Epidemiology
TRACO 2019 - K-RAS and Epidemiology
Treatment for RAS-mutated mCRC
Treatment for RAS-mutated mCRC
RAS/RAF Targeted Gene Panel by Next Generation Sequencing, Tumor
RAS/RAF Targeted Gene Panel by Next Generation Sequencing, Tumor
Novel Therapies Targeting KRAS in Lung Cancer & RAS-Altered Tumors
Novel Therapies Targeting KRAS in Lung Cancer & RAS-Altered Tumors
RAS Mutation Testing in mCRC
RAS Mutation Testing in mCRC
RAS mutations and personalized cancer care: Targeting the future
RAS mutations and personalized cancer care: Targeting the future
Revolution Medicines RAS(ON) inhibitors MoA animation
Revolution Medicines RAS(ON) inhibitors MoA animation
Overcoming the Undruggable Nature of the Most Common Human Oncogene K-Ras
Overcoming the Undruggable Nature of the Most Common Human Oncogene K-Ras
Oncogenes Explained: RAS, HER2, BCR-ABL, and Cancer Targeted Therapy
Oncogenes Explained: RAS, HER2, BCR-ABL, and Cancer Targeted Therapy
Drugging the
Drugging the "Undruggable" K-Ras Oncogene | Kevan Shokat
RAS Oncoproteins Therapeutic Vulnerabilities
RAS Oncoproteins Therapeutic Vulnerabilities
Targeting the Oncogenic State of RAS with Tri-Complex Inhibitors
Targeting the Oncogenic State of RAS with Tri-Complex Inhibitors
What is the best treatment for RAS wild-type metastatic colorectal cancer?
What is the best treatment for RAS wild-type metastatic colorectal cancer?
Extended RAS Testing in Metastatic Colorectal Cancer
Extended RAS Testing in Metastatic Colorectal Cancer
Tanios Bekaii Saab, MD: RAS Mutations and the Sequence of Therapies
Tanios Bekaii Saab, MD: RAS Mutations and the Sequence of Therapies
RAS Status and Treatment Decisions in Metastatic CRC
RAS Status and Treatment Decisions in Metastatic CRC